phase readout
saveNCT07684820: To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
RECRUITINGupdated 11h ago
community read0 votes
Sponsor: Expedition Therapeutics, Inc. Phase: PHASE2. Conditions: Chronic Obstructive Pulmonary Disease (COPD)
view source ↗
comments(0)
5-min edit window · permanent after that